Hopefully this can get to the upper teens in the next few days on no news. Not much value ascribed to their projects a.t.m.But if there is some news in the pipeline, then maybe a higher target.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%